Circulating tumor DNA as a promising biomarker of relapse risk for stage II-III colorectal cancer.

作者
Gong Chen,Feng Wang,Junjie Peng,Sanjun Cai,Kefeng Ding,Qian Xiao,Fulong Wang,Xiaojun Wu,Zhizhong Pan,Peirong Ding,Ling-Heng Kong,Desen Wan,Xiaojun Fan,Rui Liu,Hua Bao,Junli Zhang,Jiaohui Pang,Xue Wu,Yang Shao,Rui‐Hua Xu
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:38 (15_suppl): 4079-4079 被引量:2
标识
DOI:10.1200/jco.2020.38.15_suppl.4079
摘要

4079 Background: About 30-50% colorectal cancer patients undergoing a curative resection will experience disease recurrence ultimately. Early detection of recurrence is of great significance for improving the prognosis of colorectal cancer patients. Circulating tumor DNA (ctDNA) has been suggested to be a promising biomarker for postoperative surveillance and prognosis prediction in various cancers including colorectal cancer. However, its performance in predicting early recurrence of colorectal cancer as well as appropriate testing procedures still needs large-scale prospective studies to evaluate. Methods: A total of 246 patients with stage II-III colorectal cancer and underwent curative resection from three clinical centers of China were enrolled in this multicenter prospective cohort study. Tissue samples as well as serial plasma samples before surgery, 7 days and 6 months after surgery and 3 months interval afterwards until recurrence were collected, and subjected to deep targeted-panel sequencing containing 425 cancer-related genes. ctDNA baseline genomic alterations and dynamic changes were analyzed. Its performance in predicting early recurrence was evaluated and compared with other clinical routine investigations, including serum biomarkers CEA and CA199, and CT examination. Results: The ctDNA positive rates at baseline (before surgery) and 7 days after surgery were 72.9% and 18.1% respectively. Among 199 patients with complete survival data, 18 patients were recurrent during follow up period with a median disease-free survival of 280.5 days (114-461 days). At baseline, high clinical stage (p = 0.035), and PTEN mutation (p = 0.009) were significantly associated with increased recurrent risk; while APC mutation (p = 0.04) predicted a decreased recurrent risk. Detection of ctDNA 7 days after surgery [HR: 5.9 (1.94-17.97); p = 0.0004] or any time point before clinical recurrence [HR: 6.14 (2.3-16.38); p < 0.0001] was associated with a significantly higher recurrent risk, and the HR increased accordingly with ctDNA mutation level. In multivariate analyses, ctDNA status was independently associated with relapse after adjusting for known clinicopathological risk factors. CEA status was not significantly (p > 0.4) associated with disease-free survival. A risk scoring model comprising of clinical variables and ctDNA detection after surgery was constructed and can predict 18-month recurrence with an AUC of 0.77. Conclusions: ctDNA is a promising marker of risk stratification, and early relapse detection in resected stage II/III CRC patients. Clinical trial information: NCT03312374 .

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhang完成签到,获得积分10
1秒前
1秒前
汉堡包的应助被酒辞采纳,获得10
2秒前
赘婿的应助被QQ采纳,获得10
2秒前
充电宝的应助被cm采纳,获得10
4秒前
5秒前
6秒前
GIN的应助被Reaper采纳,获得10
7秒前
陈攀完成签到,获得积分10
9秒前
9秒前
二三发布了新的文献求助10
9秒前
ding的应助被JH_Yang采纳,获得10
9秒前
112完成签到 ,获得积分10
9秒前
思源的应助被嘻嘻哈哈顺利采纳,获得30
11秒前
zgm完成签到,获得积分10
11秒前
11秒前
王人捷发布了新的文献求助30
13秒前
搜集达人的应助被追寻夏槐采纳,获得20
13秒前
BIGDUCK完成签到,获得积分10
14秒前
FashionBoy的应助被vc采纳,获得10
14秒前
15秒前
16秒前
GG酱发布了新的文献求助30
16秒前
酷波er的应助被眼睛大初之采纳,获得10
17秒前
18秒前
田様的应助被鹦鹉采纳,获得10
18秒前
黄橙橙完成签到 ,获得积分10
19秒前
19秒前
syvshc的应助被含蓄的冰绿采纳,获得10
20秒前
lucky完成签到 ,获得积分10
21秒前
21秒前
22秒前
Ferry完成签到,获得积分10
23秒前
23秒前
JH_Yang发布了新的文献求助10
24秒前
Nole的应助被hannah采纳,获得10
25秒前
zZZZ发布了新的文献求助10
26秒前
26秒前
Ryan发布了新的文献求助10
26秒前
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192776
求助须知:如何正确求助?哪些是违规求助? 9579206
关于积分的说明 21864151
捐赠科研通 7792348
什么是DOI,文献DOI怎么找? 3437041
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483916